Communications publiées lors de congrès ou colloques nationaux et internationaux (36)

  1. 3. Chraibi, S., Spires, J. J., Amighi, K., & Wauthoz, N. (2019). In silico Prediction of Pharmacokinetic Parameters after Cisplatin Intravenous and Endotracheal Administration Using GastroPlus TM Software. Journal of Aerosol Medicine and Pulmonary Drug Delivery,(32), 2 , 28-30. doi:10.1089/jamp.2019.ab01.abstracts
  2. 4. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2018). Impact of the capsule type on the aerodynamic performances of a fluticasone-based dry powder under optimal and suboptimal inhalation airflows. Abstract book of DDL28. Vol. 29 (3 ed., p. 6) Drug Delivery to the Lung(28: 6-8 december 2017: Edinburg).
  3. 5. Rosiere, R., Chraibi, S., Albasry, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2018). Development of paclitaxel nanocrystal-based dry powder formulations for targeted therapy of lung tumours by inhalation. Abstracts from the Aerosol Society Drug Delivery to the Lungs. Vol. 31 (2 ed., p. 5) Drug Delivery to the Lungs(28: 6-8 december 2018: Edinburg).
  4. 6. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2017). Impact of different capsules for dry powder inhalers on the aerodynamic performances of formoterol-based binary and ternary blends. In Abstracts from the Aerosol Society Drug Delivery to the Lungs 27: Vol. 30 (p. 3132). (4). Journal of Aerosol Medicine and Pulmonary Drug Delivery.
  5. 7. Levet, V., Rosiere, R., Amighi, K., & Wauthoz, N. (2017). Local and systemic pharmacokinetic evaluation of immediate-release and controlled-release cisplatin dry powders for inhalation against lung cancer. In Abstracts from the Aerosol Society Drug Selivery to the Lungs 27: Vol. 30 (pp. 31-32). (4). Journal of Aerosol Medicine and Pulmonary Drug Delivery.
  6. 8. Levet, V., Rosiere, R., Hecq, J., Langer, I., Amighi, K., & Wauthoz, N. (2017). Tolerance of Cisplatin Dry Powders for Inhalation and Efficacy on an Orthotopic Grafted Lung Tumor Preclinical Model. In R. R. N. Dalby, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2017 (pp. 335-340) Virginia, USA: Virginia Commonwealth University.
  7. 9. Levet, V., Amighi, K., & Wauthoz, N. (2016). Development of Cisplatin-based Dry Powder for Inhalation with Controlled Release Properties for the Lung Cancer Therapy. Respiratory Drug Delivery 2016. Vol. 3 (pp. 549-552) RDD(17-21/04/2016: Phoenix Arizona).
  8. 10. Wauthoz, N., Hennia, I., Diez, F., & Amighi, K. (2016). Influence of Different Capsules for Inhalation on the Aerodynamic Performance of Formoterol Dry Powder Formulation at Different Flow Rates. Respiratory Drug Delivery 2016. Vol. 3 (pp. 553-556) RDD(17-21/04/2016: Phoenix Arizona).
  9. 11. Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2016). Development of siRNA-loaded Chitosan Nanoparticles targeting Galectin-1 for the Treatment of Glioblastoma Multiforme via Intranasal Administration. Respiratory Drug Delivery 2016. Vol. 3 (pp. 573-578) Respiratory Drug Delivery(17-21/04/2016: Phoenix Arizona).
  10. 12. Wauthoz, N., Hennia, I., Deleers, M., Diez, F., & Amighi, K. (2016). Evaluation of the aerodynamic performance of formoterol dry powder using different capsules for inhalation: hypromellose versus gelatin from Qualicaps and Capsugel. In Abstracts from The Aerosol Society Drug Delivery To the Lung 26: Vol. 29 (pp. 28-29). (3). Journal of Aerosol Medicine and Pulmonary Drug Delivery.
  11. 13. Merlos, R., Wauthoz, N., Belhassan, L., Sebti, T., Traina, K., Vanderbist, F., & Amighi, K. (2015). Scaling-up of an Itraconazole-based Dry Powder for Inhalation from a Lab-sized Büchi Mini Spray Dryer B-290 to a Pilot Mobile Minor Spray Dryer. In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2015: Book 2 (pp. 441-445) USA: Virginia Commonwealth University.
  12. 14. Wauthoz, N., Hennia, I., Deleers, M., Diez, F., & Amighi, K. (2015). Marketed Formoterol Inhalation Aerosols: A comparative Evaluation to Determine the Place of Capsule-based Dry Powder Inhalers (DPIs). In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2015 (pp. 453-457). (book 2). USA: Virginia Commonwealth University.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>